Immunology in medical practice. II. Antibodies against phospholipids and pregnancy;Immunologie in de medische praktijk. II. Antifosfolipideantistoffen bij zwangerschap

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 37, 1997, Pages 1769-1773

  Derksen, R H W M ^a   Christiaens, G C M L ^a,c   Kater, L ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Afd Reumatologie en Klin Immunol   (Netherlands)

^c Afd Obstetric en Gynaecologie ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

FETUS DEATH; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL DEATH; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOSIS;

EID: 0030875928     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Cervera R, Asherson RA, Lie JT. Clinicopathologic correlations of the antiphospholipid syndrome. Semin Arthritis Rheum 1995;24: 262-72.
2. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989;20:52-67.
3. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of lupus anticoagulants. Thromb Haemost 1991;65:320-2.
4. Triplett DA. Antiphospholipid antibodies: proposed mechanisms of action Am J Reprod Immunol 1992;28:211-5.
5. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 1994;84:2854-67.
6. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
7. Fishman P, Shoenfeld Y. Lessons from experimental antiphospholipid syndrome (APLS). Semin Clin Immunol 1993;6:39-46.
8. Out HJ, Derksen RHWM, Christiaens GCML. Systemic lupus erythematosus and pregnancy. Obstet Gynecol Surv 1989;44:585-91.
9. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983;i:1361-3.
10. Carreras LO, Vermylen J, Spitz B, Assche A van. 'Lupus' anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death Br J Obstet Gynaecol 1981;88:890-4.
11. Cowchock S, Smith JB, Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986;155:1002-10.
12. Edelman P, Rouquette AM, Verdy E, Elias A, Cabane J, Cornet D, et al. Autoimmunity, fetal losses, lupus anticoagulant: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression? Hum Reprod 1986;1:295-7.
13. Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987;30:601-6.
14. Howard MA, Firkin BG, Healy DL, Choong SCC. Lupus anticoagulant in women with multiple spontaneous miscarriage. Am J Hematol 1987;26:175-8.
15. Unander AM, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol 1987;156:114-9.
16. Barbui T, Cortelazzo S, Galli M, Parazzini F, Radici E, Rossi E, et al. Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fertil Steril 1988;50:589-92.
17. Maier DB, Parke A. Subclinical autoimmunity in recurrent aborters. Fertil Steril 1989;51:380-5.
18. Out HJ, Bruinse HW, Christiaens GCML, Vliet M van, Meilof JF, Groot PG de, et al. Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis 1991;50:553-7.
19. Balasch J, Font J, Lopez-Soto A, Cervera R, Jové I, Casals FJ, et al. Antiphospholipid antibodies in unselected patients with repeated abortion. Hum Reprod 1990;5:43-6.
20. Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991;77:854-8.
21. Creagh MD, Malia RG, Cooper SM, Smith AR, Duncan SLB, Greaves M. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. J Clin Pathol 1991;44: 45-7.
22. MacLean MA, Cumming GP, McCall F, Walker JJ, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 1994;101:103-6.
23. Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med 1991;325:1063-6.
24. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152-6.
25. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614-20.
26. Reece EA, Gabrielli S, Cullen MT, Zheng XZ, Hobbins JC, Harris EN. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990;163(1 Pt 1):162-9.
27. Shapiro GA. Antiphospholipid syndrome in obstetrics and gynecology. Semin Thromb Hemost 1994;20:64-70.
28. Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993;19:235-47.
29. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-23.
30. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439-43.
31. Out HJ, Bruinse HW, Christiaens GCML, Vliet M van, Groot PG de, Nieuwenhuis HK, et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26-32.
32. Trudinger BJ, Stewart GJ, Cook CM, Connelly A, Exner T. Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms. Obstet Gynecol 1988;72:215-8.
33. Derksen RHWM, Bruinse HW, Groot PG de, Kater L. Pregnancy in systemic lupus erythematosus: a prospective study. Lupus 1994;3: 149-55.
34. Derksen RHWM, Groot PG de, Kater L, Nieuwenhuis HX. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment. Ann Rheum Dis 1993;52: 689-92.
35. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
36. Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-3.